Alamar Biosciences, INC

Market Movers (8-K)

NASDAQ
ALMR
Alamar Biosciences, INC
8-K: Alamar Biosciences Reports Director Passing, Board Changes
Alamar Biosciences announced the passing of board member Ian Ratcliffe and subsequent adjustments to its board size and committee appointments.

Schedule 13D - Activist Investments

NASDAQ
ALMR
Alamar Biosciences, INC
SCHEDULE: Sands Capital Adjusts Alamar Biosciences Stake Post-Director Passing
Sands Capital Life Sciences Pulse Fund II, L.P. reports a 6.1% stake in Alamar Biosciences, Inc. following the passing of board member Ian Ratcliffe.

Schedule 13G - Passive Investments

NASDAQ
ALMR
Alamar Biosciences, INC
SCHEDULE: Sherpa Healthcare Funds Increase Stake in Alamar Biosciences
Sherpa Healthcare Fund II, L.P. and Sherpa Healthcare Co-Investment Fund, L.P., along with Daqing Cai, have reported beneficial ownership of 7.2% of Alamar Biosciences, Inc. common stock.